Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium carbonate plus lamotrigine versus lamotrigine monotherapy for maintenance treatment of bipolar disorder in women of childbearing age
ChiCTR2000038166Phase 4Recruiting
- Sponsor
- Beijing Anding Hospital
- Start
- Sep 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in bipolar disorder (BD) comparing Lithium carbonate combined with lamotrigine with Lamotrigine (2 arms). Primary endpoints: Recurrence rate and Time to recurrence. Started Sep 2020; status: recruiting.
02
Drugs
lithium carbonatelamotrigine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on ChiCTR2000038166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038166.